Status:
TERMINATED
Safety, Tolerability, Pharmacokinetics and -Dynamics of Multiple Rising Oral Doses of BI 113823 in Patients Patients With Osteoarthritis of the Knee
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Osteoarthritis
Eligibility:
All Genders
35-65 years
Phase:
PHASE1
Brief Summary
The objective of the study is to investigate the safety and tolerability of BI 113823 in male and female patients with osteoarthritis, following oral administration of BI 113823 with repeated rising d...
Eligibility Criteria
Inclusion
- Inclusion criteria patients with osteoarthritis
- Exclusion criteria
Exclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01207973
Start Date
September 1 2010
Last Update
November 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1272.2.1 Boehringer Ingelheim Investigational Site
München, Germany